$ 60 million burnout in sheet! Come on. What a bad story. I suspect that they messed up the formulation in production from the EU site to the USA. Seems that something has been done profoundly wrong. Simply the two data trial do not match. I understand if there was a mixed result where the formula was having a better patient response than standard care, but eventually not as satisfactory as planned; but to say that the Zee Upton and TIS/FTT formulation is actually less effective than standard care is just non sense.
Moreover, what for they appointed Tyler Collison for partnering and why provide such announcement that has misled so many investors in Australia and Europe?
FTT Price at posting:
0.3¢ Sentiment: Buy Disclosure: Held
